Roche beats revenue estimates, shares slip as copycats eat into Xolair sales

By Patrick Wingrove and Marleen Kaesebier
ZURICH/ LONDON, Oct 22 - Swiss drugmaker Roche beat third-quarter sales expectations on Thursday, supported by steady demand for key medicines such as Ocrevus to buy time as it looks abroad to resto
Read more...